L Capital, the Asian private equity arm of LVMH Moët Hennessy Louis Vuitton, has invested $24.7 million (NT $750 million) in Taiwan-based skincare products maker DR.WU Skincare, according to a statement.
L Capital will hold a significant minority stake in the company. Further financial details were not disclosed.
DR.WU is Taiwan’s leading clinical skincare brand and was founded in 2003 by dermatologist Yin-Ching Wu, according to the statement.
L Capital intends to use its resources and network to expand the brand into foreign markets.
“I firmly believe that the combination of DR.WU’s strong product knowledge and well-established brand name, with our insights on marketing as well as our market access will make for a good case study for international market expansion,” said managing partner of L Capital Asia, Ravi Thakran, in the statement.
The deal is the firm's second this month. Earlier in March, L Capital bought a controlling stake in Asia-based restaurant, lounge and club operator Ku Dé Ta, Private Equity International reported earlier.
In December, the firm took a 40 percent stake in Australian sportswear firm 2XU in a deal valued at A$75 million.
L Capital closed its $950 million vehicle L Capital Asia II in August 2013. The firm invests in consumer businesses that will benefit from the growing discretionary consumption in emerging Asian markets, across select sectors of lifestyle consumption.